Scisparc achieves major milestone with first patient dosed in autism spectrum disorder clinical trial

First patient has been dosed in the randomized, controlled, double blind clinical trial for autism spectrum disorder in pediatric patients

SPRC Ratings Summary

SPRC Quant Ranking